# FDA Inspection 1261481 - Oklahoma Blood Institute Arkansas Blood Institute - February 06, 2025

Source: https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute/c8d1d0c2-01f2-4516-a178-397c9d33b72e
Source feed: FDA_Inspections

> FDA Inspection 1261481 for Oklahoma Blood Institute Arkansas Blood Institute on February 06, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1261481
- Company Name: Oklahoma Blood Institute Arkansas Blood Institute
- Inspection Date: 2025-02-06
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1261481 - 2025-02-06](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute/01021d87-f5e8-4ff6-8fbf-6403fa6b087e)
- [FDA Inspection 1169916 - 2022-04-28](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute/532e3e1b-83b8-4aff-bf45-15c7bb829cf7)
- [FDA Inspection 1169916 - 2022-04-28](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute/e10d4461-ad4f-4fc3-92a1-54c4a43db861)
- [FDA Inspection 1060711 - 2018-07-20](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute/620e8ad3-5e3b-45bb-af67-02c304a47923)
- [FDA Inspection 989311 - 2016-10-19](https://www.keypedia.com/records/fda_inspections/oklahoma-blood-institute-arkansas-blood-institute/6d11b452-ba9e-4ec2-8399-eddbae6c0540)

Company: https://www.keypedia.com/companies/oklahoma-blood-institute-arkansas-blood-institute/2cb6726d-8658-4eea-b8bb-4c7e61e81e41

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
